Home Care
ARALAST AATmosphere
Call on our team of personal advocates to support Alphas and their families at ARALAST AATmosphere.
Many Alphas choose to receive their weekly ARALAST therapy in their home or some other convenient location, such as their workplace. For patients who choose this option, Baxter distributes ARALAST through highly specialized homecare companies that will help make these arrangements.
You and your healthcare provider can select the homecare company that best fits your needs. Your healthcare provider will then contact the homecare company to begin the process.
These specialized homecare companies provide a broad range of direct care and support services that can benefit you.
What home care means |
How it benefits you |
Comprehensive in-home care |
You will be cared for by a team of highly qualified, experienced pharmacists, nurses, and client representatives |
Education and nursing support |
Professional resources for all therapy options, from self-infusion to nurse-administered infusion Convenience within your home or workplace |
Advocacy programs |
Case managers work with you to advocate for access to benefits and to identify and secure appropriate reimbursement levels Get information on insurance issues and state programs |
Nurse-to-physician information |
Regular communication with the physician ensures high quality of your care |
Nationwide service |
Comprehensive service wherever you need therapy |
The specialty homecare providers selected by Baxter are
Accredo Therapeutics 1640 Century Center Parkway, Suite 105 Memphis, TN 38134 1-866-6ALPHA1 (866-625-7421) www.accredotx.com |
 |
Coram Healthcare 1675 Broadway, Suite 900 Denver, CO 80202 1-866-FOR-A1PI (866-367-2174) www.coramhc.com |
To learn more about the services available to you through a specialty homecare company, call 1-866-ARALAST (272-5278).
These links are provided for your convenience. However, they lead to external websites not created, managed, or maintained by Baxter. Baxter is not responsible for, and does not necessarily endorse, the opinions or products represented on these external pages.
ARALAST [Alpha1-Proteinase Inhibitor (Human)] is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
Please review the Important Safety Information and the Full Prescribing Information
 |
To view PDF, you will need Adobe® Acrobat® Reader® software. |
